Navigation Links
Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference
Date:10/11/2011

nd initially submitted the ADASUVE NDA in December 2009.  In October 2010, the Company received a Complete Response Letter from the FDA regarding the application.  The Company completed an end-of-review meeting with the FDA in December 2010 and a Risk Evaluation and Mitigation Strategy (REMS) guidance meeting with the FDA in April 2011.  The ADASUVE NDA was resubmitted on August 4, 2011, and has a Prescription Drug User Fee Act (PDUFA) goal date of February 4, 2012.  The FDA has indicated that it will likely present the ADASUVE application to an Advisory Committee during the review period.  

Alexza also plans to file the ADASUVE Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) in the fourth quarter of 2011.  In October 2011, the Company established a commercial partnership for ADASUVE with Grupo Ferrer International, S.A.  Grupo Ferrer is a leading pharmaceutical company in Europe with extensive operations in the Americas, and is Alexza's partner in the registration, distribution and promotion of ADASUVE in Europe, Latin America, Russia and the Commonwealth of Independent States countries.  

For more information about Alexza, the Staccato system technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

The anticipated presentation will contain forward-looking statements that involve significant risks and uncertainties. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs, including the adequacy of the Company's capital to support the Company's operatio
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015  Mail-service and ... consumers, employers and government health plans $23.3 ... released by the Pharmaceutical Care Management Association (PCMA). ... drugs offers one of the easiest ways to ... Mark Merritt . "Policymakers should resist efforts ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015  BD Life ... Company) (NYSE: BDX ), a leading ... innovative company focused on enabling high-resolution biology, today ... unique solutions for highly multiplexed cell isolation and ... are promoting BD,s powerful BD FACS™ single-cell sorting ...
(Date:2/26/2015)... 2015  Lyric Pharmaceuticals Inc. today announced the initial ... million. The financing, co-led by RiverVest Venture Partners, Sante ... Venture Partners. Lyric is a clinical-stage ... , M.D., M.B.A., President & Chief Executive Officer and ... In 2014, Lyric closed a seed financing round of ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3
... to respond to agency during first quarterKENILWORTH, N.J., Jan. ... today announced that the U.S. Food and Drug Administration ... (asenapine) sublingual tablets in the acute treatment of schizophrenia ... or mixed episodes associated with bipolar I disorder in ...
... Clinical Trial for the Treatment of Pediatric Eosinophilic Esophagitis ... Cephalon, Inc . (Nasdaq: CEPH ) ... today announced that the companies have signed an agreement ... capital stock of Ception. Under the terms of ...
Cached Medicine Technology:U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder 2Cephalon Signs Option Agreement to Acquire Ception Therapeutics 2Cephalon Signs Option Agreement to Acquire Ception Therapeutics 3Cephalon Signs Option Agreement to Acquire Ception Therapeutics 4
(Date:2/27/2015)... Muscular Dystrophy Association research grantee Charles ... University, recently announced a potentially game-changing advance in ... Duchenne muscular dystrophy (DMD). The results were published ... discuss their implications at MDA's 2015 Scientific Conference, ... , Background: Gersbach and team are investigating ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 According to ... in the China Dental Industry in 2013 rose by ... the total amount of revenue generated by the industry ... that was registered by the industry in 2013. ... The report has identified the oral industry as a ...
(Date:2/27/2015)... UT (PRWEB) February 27, 2015 ... Worst Commuter Cities in Florida " report today. ... from the 2013 U.S. Census Bureau survey, considering ... the time of the survey. , The report ... including methods of commuting and a breakdown of ...
(Date:2/27/2015)... On time and under budget, the doors ... Inside and out, the nearly 900,000-square-foot facility makes good ... the tornado-ravaged St. John’s Regional Medical Center with a ... just 46 months after the tornado hit Joplin, which ... to plan, design and construct a similarly sized hospital,” ...
(Date:2/27/2015)... Fairfax, VA (PRWEB) February 27, 2015 ... currently accepting applications for its next class of Fellows ... the field of radiology business management. , Since ... the significant contributions made by RBMA members to the ... is a prestigious recognition because each Fellow candidate must ...
Breaking Medicine News(10 mins):Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 3Health News:40 Best and Worst Commuter Cities in Florida Announced by Obrella 2Health News:New Hospital Built to Stand Against Nature 2Health News:New Hospital Built to Stand Against Nature 3Health News:New Hospital Built to Stand Against Nature 4Health News:RBMA Issues Call for Fellowship Applicants 2
... uptick in teen pregnancies in 2006 , , MONDAY, April ... United States declined from 1990 to 2004, as did ... among unmarried women increased slightly during that period. , ... Pregnancy Rates by Outcome for the United States, 1990-2004" ...
... April 14 A new Web resource,that allows ... the delivery of,health services was launched today by ... - called the Health Care Innovations Exchange -,is ... Care Innovations Exchange is the federal government,s,repository for ...
... in the blood of chronic sinusitis sufferers that may ... researchers say. , They used a sophisticated research tool ... and found among 96 chronic sinusitis patients a profile ... diagnose this disease with a totally objective test that ...
... First-Timers Faldo, Weekley, Snedeker, Howell III, Diaz and ... ... and Billy,Andrade, PGA TOUR Professionals and co-hosts of the CVS Caremark Charity,Classic, ... Caremark Charity Classic is set for June 22 - 24 at,Rhode Island ...
... the development of precancerous growths in a two-step model ... pathways known to contribute to cancer growth and development, ... Cancer Center report today at the American Association for ... contrast, activated those pathways, said first author Tricia Moore, ...
... doctors from,across the U.S. meet here April 17-20 ... of three "Health Disparities and,Hispanics Leadership Summits" by ... Hispanic Medical Association (NHMA)., The doctors are ... Medical Association, a nonprofit group based in Washington, ...
Cached Medicine News:Health News:Teen Pregnancies, Abortions Drop From 1990 to 2004: CDC 2Health News:Teen Pregnancies, Abortions Drop From 1990 to 2004: CDC 3Health News:AHRQ Web Resource Features 100 Examples of Health Care Innovations and Tools 2Health News:AHRQ Web Resource Features 100 Examples of Health Care Innovations and Tools 3Health News:Potential blood test for chronic sinusitis identified 2Health News:CVS Caremark Charity Classic Golf Tournament Unveils 10th Anniversary Field 2Health News:CVS Caremark Charity Classic Golf Tournament Unveils 10th Anniversary Field 3Health News:Calorie restriction limits Calorie restriction inhibits, obesity fuels development of epithelial can 2Health News:NHMA, Office of Minority Health Unveil Findings of Summits to Eliminate Health Disparities at Conference April 17-20 2
... integration of Trabecular Metal material ... design results in a fusion of ... meets surgeon demands for initial and ... wide variety of shell and liner ...
Trident Hemispherical Acetabular Shells are a true hemispherical shape designed to achieve press-fit fixation by under-reaming the acetabulum....
The Bofor acetabular revision cup addresses cases of severe acetabular destruction....
Implex cemented hip stem....
Medicine Products: